Role of Angiotensin-(1-7) via MAS receptor in human sperm motility and acrosome reaction.


Journal

Reproduction (Cambridge, England)
ISSN: 1741-7899
Titre abrégé: Reproduction
Pays: England
ID NLM: 100966036

Informations de publication

Date de publication:
03 2020
Historique:
received: 24 06 2019
accepted: 22 12 2019
pubmed: 24 12 2019
medline: 8 5 2021
entrez: 24 12 2019
Statut: ppublish

Résumé

Rennin-angiotensin system (RAS) has been involved in sperm function, even so, little is known about the implication of one of the RAS axis formed by Ang-(1-7) (angiotensin-(1-7)) and MAS receptor. Hence, in the present work, we focused on elucidating the function of the MAS receptor in human spermatozoa. We analyzed the expression and localization of MAS receptor in human spermatozoa and we observed if its activation is able to modulate the sperm motility of normal motility and/or asthenozoospermic patients, as well as, the acrosome reaction of the spermatozoa. MAS receptor is present in human mature spermatozoa, not only at the mRNA level but also at protein level. MAS is localized at the acrosome region, as well as, in the tail of spermatozoa. The sperm incubation with MAS agonist Ang-(1-7) activates at dose-dependent manner the PI3K/AKT pathway (P < 0.01 vs control) and improves the motility of asthenozoospermic patients (P < 0.01 vs control), which is blocked by the specific antagonist (A779) (P < 0.01), but it do not modulate the acrosome reaction. These findings suggest that the ACE2/Ang-(1-7)/Mas axis may be a useful biochemical tool for the treatment of male infertility related to sperm mobility.

Identifiants

pubmed: 31869308
doi: 10.1530/REP-19-0274
pii: REP-19-0274
doi:
pii:

Substances chimiques

7-Ala-angiotensin (1-7) 0
Peptide Fragments 0
Proto-Oncogene Mas 0
Proto-Oncogene Proteins 0
Receptors, G-Protein-Coupled 0
Angiotensin II 11128-99-7
Angiotensin I 9041-90-1
angiotensin I (1-7) IJ3FUK8MOF

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-249

Auteurs

Asier Valdivia (A)

Department of Cell Biology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Lorea Cortés (L)

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Maider Beitia (M)

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Lide Totorikaguena (L)

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Naiara Agirregoitia (N)

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Beatriz Corcostegui (B)

Human Reproduction Unit, Cruces Hospital, Biocruces, University of the Basque Country, Leioa, Bizkaia, Spain.

Luis Casis (L)

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Roberto Matorras (R)

Human Reproduction Unit, Cruces Hospital, Biocruces, University of the Basque Country, Leioa, Bizkaia, Spain.
IVI (Instituto Valenciano de Infertilidad), Bilbao, Bizkaia, Spain.

Jon Irazusta (J)

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Ekaitz Agirregoitia (E)

Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Bizkaia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH